World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
26412
World Ranking
14616
National Ranking
210

Overview

Inti Zlobec is affiliated with the University of Bern in Switzerland and has a research focus primarily within the field of Medicine, with extensive work in Oncology, Radiology, Nuclear Medicine and Imaging, Artificial Intelligence, Immunology, and Molecular Biology.

The scientist's research topics include Radiomics and Machine Learning in Medical Imaging, AI in cancer detection, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Screening and Detection, Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, and Cancer Cells and Metastasis.

Recent publications by Inti Zlobec include:

  • Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front, 2020, Cell
  • Tumour budding in solid cancers, 2020, Nature Reviews Clinical Oncology
  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer, 2020, Journal of Clinical Oncology
  • Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front, 2020, Cell
  • A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations, 2020, Neuroendocrinology

Frequent co-authors collaborating with Inti Zlobec include:

  • Alessandro Lugli
  • Heather Dawson
  • Irıs D. Nagtegaal
  • Martin D. Berger
  • Eva Karamitopoulou

Key publication venues for Zlobec's work consist of:

  • Bern Open Repository and Information System (University of Bern)
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Modern Pathology
  • Cancer Research
  • Zenodo (CERN European Organization for Nuclear Research)

Best Publications

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

    Alessandro Lugli;Richard Kirsch;Yoichi Ajioka;Fred Bosman

  • Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front.

    Christian M. Schürch;Salil S. Bhate;Graham L. Barlow;Darci J. Phillips

  • Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

    Raoul A. Droeser;Raoul A. Droeser;Christian Hirt;Christian Hirt;Carsten T. Viehl;Daniel M. Frey

  • Synaptic proximity enables NMDAR signalling to promote brain metastasis

    Qiqun Zeng;Iacovos P. Michael;Peng Zhang;Sadegh Saghafinia

  • High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients

    Daniel M. Frey;Raoul A. Droeser;Carsten T. Viehl;Inti Zlobec

  • Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

    A Lugli;G Iezzi;I Hostettler;M G Muraro

  • Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget

    Inti Zlobec;Alessandro Lugli

  • Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer

    J R Jass;K Baker;I Zlobec;T Higuchi;T Higuchi

  • Prognostic and predictive factors in colorectal cancer

    Inti Zlobec;Alessandro Lugli

  • Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.

    Inti Zlobec;Michel P. Bihl;Heike Schwarb;Luigi Terracciano

  • Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

    Enric Domingo;Enric Domingo;Luke Freeman-Mills;Emily Rayner;Mark Glaire

  • Tumor budding in colorectal cancer—ready for diagnostic practice?

    Viktor H. Koelzer;Inti Zlobec;Alessandro Lugli

  • Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles

    P. Minoo;I. Zlobec;M. Peterson;L. Terracciano

  • Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality

    Claude A. Fischer;Inti Zlobec;Edith Green;Simone Probst

  • Tumour budding in solid cancers

    Alessandro Lugli;Inti Zlobec;Martin D Berger;Richard Kirsch

  • Selecting immunohistochemical cut‐off scores for novel biomarkers of progression and survival in colorectal cancer

    Inti Zlobec;Russell Steele;Luigi Terracciano;Jeremy R Jass

  • Tumour budding: a promising parameter in colorectal cancer

    A Lugli;Eva Karamitopoulou;I Zlobec

Frequent Co-Authors

Alessandro Lugli
Alessandro Lugli University of Bern
Luigi Terracciano
Luigi Terracciano University Hospital of Basel
Aurel Perren
Aurel Perren University of Bern
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
Jeremy R. Jass
Jeremy R. Jass Imperial College London
Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg
Iris D. Nagtegaal
Iris D. Nagtegaal Radboud University
Giulio C. Spagnoli
Giulio C. Spagnoli University Hospital of Basel
George N. Thalmann
George N. Thalmann University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to diverse online degree options beyond traditional MD programs. Many healthcare professionals are choosing flexible online learning to support their careers, whether in clinical settings or healthcare administration.

For those interested in leadership and management, evaluating the cost of mha degree is an essential step toward a career in healthcare administration. Nursing professionals looking for advanced practice can consider msn to dnp programs online, which provide a pathway to the Doctor of Nursing Practice from a Master’s in Nursing.

Pharmacists can also benefit from flexible study options, such as a 3 year online pharmd program, which enables students to qualify as a Doctor of Pharmacy without putting their careers on pause. Additionally, the rapid growth of health data has boosted demand for graduates with a health information technology online degree, preparing professionals to manage and protect critical healthcare information.

Each of these online pathways offers flexibility, affordability, and specialized career potential within the evolving healthcare industry.

Best Scientists Citing Inti Zlobec

Trending Scientists

Recently Published Articles